Nitrogenous bases such as pyridine are widely used as reagents and solvents in a variety of industrial and laboratory settings. Pyridine is employed as an intermediate in the manufacture of drugs, explosives, paints, disinfectants, fungicides, insecticides, herbicides, and as a denaturant for alcohol. Recent work in our laboratory has shown pyridine to be a potent inducer of hepatic microsomal cytochrome P-450 as evidenced by a 2-fold increase in P-450 content relative to uninduced microsomes and a 4-fold to 10-fold enhancement in dimethylnitrosamine, alcohol, and aniline metabolism. Benzo[a]pyrene hydroxylase and pyridine N-oxidase activities are also significantly enhanced. The electrophoretic pattern of pyridine-induced microsomes shows protein bands of enhanced intensity occurring in the region of P-450LM2, LM4, and LM6. To date, there is no information on the ability of pyridine to induce P-450 and metabolic activity in extrahepatic tissues such as the nose, lung, or kidney which may be exposed to this agent during absorption and excretion. Moreover, no information is available on pyridine-induction of non-P-450 drug metabolizing enzymes (GSH transferase, epoxide hydrolase, UDP-glucuronyltransferase) in hepatic or extrahepatic tissue. Finally, little is known about xenobiotic-mediated toxicity to tissues as a consequence of pyridine induction in affected tissues. In view of the physicochemical properties of pyridine, the finding that it induces cytochrome P-450(s) active in carcinogen metabolism, and the toxicologic significance associated with enhanced metabolic activity, we propose: 1) to examine exposure regimens for induction of drug metabolizing enzymes in rabbit nasal, lung, kidney and liver tissue; 2) to characterize the metabolic activity of nitrogenous base-induced rabbit nasal, lung, kidney, and liver cytosolic and microsomal preparations; 3) to evaluate the effect of pyridine induction of drug metabolizing enzymes on toxicity in vivo; and 4) to evaluate the propensity of other nitrogenous bases to induce drug metabolizing enzymes in rabbit nasal, lung, kidney, and liver tissue. UV-visible difference spectroscopy, SDS-PAGE, and standard metabolic assays will be employed in the characterization of induction and metabolic activity. The induction of cytochrome P-450 by volatile, water-soluble nitrogenous bases such as pyridine (which are readily absorbed through inhalation or ingestion) may result in a profound effect on toxicity of xenobiotics and on tissue susceptibility to tumorigenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
7R01ES003656-02
Application #
3251212
Study Section
Safety and Occupational Health Study Section (SOH)
Project Start
1988-04-01
Project End
1990-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
Organized Research Units
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Shukla, Upasana; Tumma, Nithin; Gratsch, Theresa et al. (2013) Insights into insulin-mediated regulation of CYP2E1: miR-132/-212 targeting of CYP2E1 and role of phosphatidylinositol 3-kinase, Akt (protein kinase B), mammalian target of rapamycin signaling in regulating miR-132/-212 and miR-122/-181a expression in pri Drug Metab Dispos 41:1769-77
Hudder, Alice; Novak, Raymond F (2008) miRNAs: effectors of environmental influences on gene expression and disease. Toxicol Sci 103:228-40
Kim, Sang K; Novak, Raymond F (2007) The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression. Pharmacol Ther 113:88-120
Kim, Sang K; Abdelmegeed, Mohamed A; Novak, Raymond F (2006) The mitogen-activated protein kinase kinase (mek) inhibitor PD98059 elevates primary cultured rat hepatocyte glutathione levels independent of inhibiting mek. Drug Metab Dispos 34:683-9
Kim, Sang K; Abdelmegeed, Mohamed A; Novak, Raymond F (2006) Identification of the insulin signaling cascade in the regulation of alpha-class glutathione S-transferase expression in primary cultured rat hepatocytes. J Pharmacol Exp Ther 316:1255-61
Abdelmegeed, Mohamed A; Carruthers, Nicholas J; Woodcroft, Kimberley J et al. (2005) Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes. J Pharmacol Exp Ther 315:203-13
Kim, Sang K; Woodcroft, Kimberley J; Oh, Soo Jin et al. (2005) Role of mechanical and redox stress in activation of mitogen-activated protein kinases in primary cultured rat hepatocytes. Biochem Pharmacol 70:1785-95
Abdelmegeed, Mohamed A; Kim, Sang K; Woodcroft, Kimberley J et al. (2004) Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress. J Pharmacol Exp Ther 310:728-36
Kim, Sang K; Woodcroft, Kimberley J; Khodadadeh, Sarah S et al. (2004) Insulin signaling regulates gamma-glutamylcysteine ligase catalytic subunit expression in primary cultured rat hepatocytes. J Pharmacol Exp Ther 311:99-108
Kim, Sang K; Woodcroft, Kimberley J; Kim, Sang G et al. (2003) Insulin and glucagon signaling in regulation of microsomal epoxide hydrolase expression in primary cultured rat hepatocytes. Drug Metab Dispos 31:1260-8

Showing the most recent 10 out of 43 publications